![]() Livemint | Sun Pharma takes skincare niche with $230 m Dusa buy Daily News & Analysis Sun Pharmaceuticalsis to buy US-based $50-million-turnover skincare company Dusa Pharma for $230 million. Sun said the deal has been approved by both the boards. Dusa will give the Indian company an entry into dermatological treatment devices where ... Sun Pharma gets US firm Dusa for $230mn |

No comments:
Post a Comment